Stockscreener 앱 받기
256.56
12.26%
-35.86
전일 마감가:
$292.42
열려 있는:
$251
하루 거래량:
1.06M
Relative Volume:
5.09
시가총액:
$6.92B
수익:
$2.58B
순이익/손실:
$-778.69M
주가수익비율:
-9.3875
EPS:
-27.33
순현금흐름:
$223.75M
1주 성능:
-14.91%
1개월 성능:
-20.37%
6개월 성능:
-10.66%
1년 성능:
-16.26%
1일 변동 폭
$251.00
$272.79
1주일 범위
$251.00
$301.47
52주 변동 폭
$211.43
$343.12
Bio Rad Laboratories Inc Stock (BIO) Company Profile
명칭
Bio Rad Laboratories Inc
전화
(510) 724-7000
주소
1000 ALFRED NOBEL DRIVE, HERCULES
Compare BIO vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BIO
Bio Rad Laboratories Inc
|
256.56 | 7.89B | 2.58B | -778.69M | 223.75M | -27.33 |
|
ABT
Abbott Laboratories
|
112.68 | 193.83B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
SYK
Stryker Corp
|
366.05 | 140.01B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
99.49 | 129.33B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
BSX
Boston Scientific Corp
|
74.73 | 109.92B | 20.08B | 2.89B | 3.82B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
75.87 | 44.36B | 6.07B | 1.06B | 799.60M | 1.8527 |
Bio Rad Laboratories Inc Stock (BIO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-10-01 | 업그레이드 | Citigroup | Neutral → Buy |
| 2024-08-28 | 개시 | Wells Fargo | Equal Weight |
| 2024-06-03 | 재개 | Jefferies | Hold |
| 2024-04-03 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2023-12-07 | 개시 | UBS | Buy |
| 2023-06-16 | 개시 | Wells Fargo | Overweight |
| 2022-12-07 | 개시 | RBC Capital Mkts | Outperform |
| 2022-08-25 | 개시 | Credit Suisse | Outperform |
| 2022-01-28 | 재확인 | Citigroup | Buy |
| 2020-01-08 | 개시 | Wells Fargo | Overweight |
| 2020-01-07 | 개시 | Citigroup | Buy |
| 2018-10-17 | 개시 | Goldman | Buy |
| 2018-09-20 | 개시 | Morgan Stanley | Equal-Weight |
| 2018-02-16 | 다운그레이드 | CL King | Buy → Neutral |
| 2017-07-13 | 개시 | Wells Fargo | Outperform |
| 2017-06-28 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2017-01-18 | 개시 | Deutsche Bank | Hold |
| 2016-10-13 | 개시 | CL King | Buy |
| 2015-05-06 | 재확인 | Jefferies | Buy |
| 2009-12-18 | 개시 | Maxim Group | Buy |
| 2009-11-06 | 개시 | Jefferies & Co | Buy |
| 2009-07-17 | 개시 | Soleil | Buy |
| 2007-09-26 | 개시 | Banc of America Sec | Buy |
| 2007-02-23 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
모두보기
Bio Rad Laboratories Inc 주식(BIO)의 최신 뉴스
Bio-Rad Laboratories (NYSE:BIO) Lowered to "Hold" Rating by Wall Street Zen - MarketBeat
Beyond the Balance Sheet: What SWOT Reveals About Bio-Rad Labora - GuruFocus
Bio-Rad Q4 2025 slides reveal modest growth amid segment divergence and strategic shifts - Investing.com Nigeria
Bio-Rad Laboratories (NYSE:BIO.B) Shares Gap DownHere's What Happened - MarketBeat
Bio-Rad Laboratories Inc (BIO) Shares Down 11.17% on Feb 13 - GuruFocus
Oversold Conditions For Bio-Rad Laboratories (BIO) - Nasdaq
Bio-Rad Laboratories (BIO) Shares Cross Below 200 DMA - Nasdaq
Bio-Rad Laboratories (NYSE:BIO) Shares Gap Down After Earnings Miss - MarketBeat
Pinterest Posts Downbeat Results, Joins DraftKings, Toast, Expedia And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Benzinga
S&P 500 Futures Drop in Premarket Trading; Pinterest, Bio-Rad Labs A Lag - Barron's
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
BIO-RAD LABORATORIES, INC. SEC 10-K Report - TradingView
Bio-Rad (BIO) Reports Q4 Revenue Growth and Strategic Initiatives - GuruFocus
Bio-Rad Laboratories, Inc. $BIO Holdings Lifted by Envestnet Asset Management Inc. - MarketBeat
Bio-Rad outlines 2026 margin expansion and 0.5%-1.5% revenue growth guidance amid operational improvements - MSN
Bio-Rad Laboratories Q4 2025 Earnings Call Transcript - MarketBeat
Bio-Rad Laboratories Q4 Earnings Call Highlights - Yahoo Finance
Bio-Rad Laboratories (NYSE:BIO.B) Posts Quarterly Earnings Results - MarketBeat
Bio-Rad (BIO) Q4 2025 Earnings Call Transcript - AOL.com
Bio-Rad: Q4 Earnings Snapshot - kare11.com
BIO: 2025 results met guidance with diagnostics growth, ddPCR momentum, and cautious 2026 outlook - TradingView
BIO: 2025 saw resilient revenue and cash flow, with diagnostics growth and ddPCR momentum offsetting margin pressures - TradingView
Earnings call transcript: Bio-Rad Labs Q4 2025 misses EPS expectations - Investing.com India
Bio-Rad: Fourth Quarter Financial Highlights - Bitget
Bio-Rad Laboratories (BIO) Q4 Earnings Miss Estimates - Yahoo Finance UK
Bio-Rad Laboratories Swings To Q4 Profit - Nasdaq
Bio-Rad shares tumble as Q4 earnings miss expectations By Investing.com - Investing.com Australia
Bio-Rad Laboratories Posts Mixed Q4 2025 Financial Results - TipRanks
Earnings Flash (BIO) Bio-Rad Laboratories, Inc. Reports Q4 Revenue $693.2M, vs. FactSet Est of $688.8M - marketscreener.com
Bio-Rad Laboratories (NYSE:BIO) Announces Quarterly Earnings Results - MarketBeat
Is Bio Rad Laboratories Inc. stock risky to hold now2025 Analyst Calls & Verified Momentum Watchlists - mfd.ru
Bio-Rad Reports Fourth-Quarter and Full-Year 2025 Financial Results - Business Wire
Bio-Rad earnings on deck as estimates drift lower ahead of report By Investing.com - Investing.com South Africa
Bio-Rad earnings on deck as estimates drift lower ahead of report - Investing.com UK
Is Bio Rad Laboratories Inc. (BUWA) stock a safe buy pre earnings2025 Top Gainers & Expert Curated Trade Ideas - mfd.ru
Can Bio Rad Laboratories Inc. (BUW) stock sustain revenue momentumTrade Risk Summary & Daily Oversold Stock Bounce Ideas - mfd.ru
Dematic Automation Solution Drives Precision and Productivity for BIO-RAD Singapore - iTWire
Bio-Rad receives AOAC international validation for EZ-Check Listeria spp. and EZ-Check Listeria monocytogenes Testing Kits - Cambridge Network
Medical Biosensors Market is expected to reach US$ 12.60 Billion - openPR.com
Allianz Asset Management GmbH Boosts Position in Bio-Rad Laboratories, Inc. $BIO - MarketBeat
Bio-Rad EZ-Check Listeria Test Kits Receive AOAC Validation - Food Safety Magazine
Multiplex Immunoassays Market to Reach US$ 6.90 Billion by 2033 - openPR.com
Atlantic Union Bankshares Corp Purchases Shares of 4,099 Bio-Rad Laboratories, Inc. $BIO - MarketBeat
Bio-Rad Laboratories (BIO) Projected to Post Earnings on Thursday - MarketBeat
The Latest in ddPCR Technology - the-scientist.com
PCR Technologies Market Is Going to Boom |• Thermo Fisher Scientific • Bio-Rad Laboratories - openPR.com
Polymerase Chain Reaction Market Set for Rapid Growth and Trend - openPR.com
United States Digital PCR Market to Reach at 7.4% CAGR by 2031; - openPR.com
DNA Sequencing Market Covering Prime Factors and Competitive - openPR.com
Mawer Investment Management Ltd. Reduces Holdings in Bio-Rad Laboratories, Inc. $BIO - MarketBeat
Veritas Asset Management LLP Has $236.66 Million Holdings in Bio-Rad Laboratories, Inc. $BIO - MarketBeat
Bio Rad Laboratories Inc (BIO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.33%
0.51%
자본화:
|
볼륨(24시간):